Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-024-02583-0, published online 5 February 2024
In Fig. 4b, Uninjected site, the labels for ‘GN+702’ and ‘GN+702 +anti-CD8α’ were incorrectly placed; the labels should be transposed, as shown in the corrected figure presented here.
In Fig. 5c, After re-inoculation, the labels for ‘GN+702’ and ‘GN+702 +anti-CD8α’ were incorrectly placed; the labels should be transposed, as shown in the corrected figure presented here.
The correction does not have any effect on the results or conclusions of the paper.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hashimoto, M., Kuroda, S., Kanaya, N. et al. Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. Br J Cancer 131, 1716–1717 (2024). https://doi.org/10.1038/s41416-024-02850-0
Published:
Issue date:
DOI: https://doi.org/10.1038/s41416-024-02850-0
